Top 5 Drug Type | Count |
---|---|
Small molecule drug | 10 |
Chemical drugs | 1 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date04 Oct 1991 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. CN |
First Approval Date01 Jan 1990 |
Target |
Mechanism ADRA2 agonists |
Active Org. |
Originator Org. |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date18 Apr 1988 |
Start Date09 Nov 2024 |
Sponsor / Collaborator |
Start Date10 Oct 2024 |
Sponsor / Collaborator |
Start Date10 Sep 2024 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Methylcantharidimide | Liver Cancer More | Approved |
Clomipramine Hydrochloride ( NET x SERT ) | Panic Disorder More | Approved |
Tizanidine Hydrochloride ( ADRA2 ) | Multiple Sclerosis More | Approved |
Oxiglutatione | Poisoning More | Approved |
Glycopyrrolate ( mAChRs ) | Duodenal Ulcer More | Approved |